Avanos Medical (NYSE:AVNS) will release its quarterly earnings report on Tuesday, 2026-02-24. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Avanos Medical to report an earnings per share (EPS) of $0.25.
The market awaits Avanos Medical's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
The company's EPS beat by $0.07 in the last quarter, leading to a 4.88% increase in the share price on the following day.
Here's a look at Avanos Medical's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.15 | 0.16 | 0.18 | 0.40 |
| EPS Actual | 0.22 | 0.17 | 0.26 | 0.43 |
| Price Change % | 5.00 | 4.00 | -2.00 | -3.00 |
Performance of Avanos Medical Shares
Shares of Avanos Medical were trading at $15.46 as of February 20. Over the last 52-week period, shares are down 2.06%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Avanos Medical visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
- No comments yet. Be the first to comment!